Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA–topoisomerase I complex
“…Among 23 isoquinolone compounds, 1 and 17–19 have been synthesized according to our established protocol ( Supplementary Scheme S1 ) [ 11 , 12 ]. Compounds 2 , 3 , 13–15 and 22 without the methylenedioxy group at R 2 were separately synthesized ( Supplementary Scheme S2 ) [ 13 , 14 , 15 , 16 ]. A newly designed synthetic method was used for phensylisoquinolone derivatives 7–10 and 21 , and these compounds were prepared in a one-step cyclization reaction using n-BuLi to link the N,N-diethyl-2-methylbenzamide and benzonitrile moieties ( Scheme 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…Isoquinolone derivatives were synthesized as described previously [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 ]. The structure of newly synthesized compounds 7– 10 and 21 was confirmed by 300 MHz (Varian Unity Plus 300 MHz; Varian Inc., Palo Alto, CA, USA) and 400 MHz (Bruker Ascend 400 MHz; Bruker Daltonik, Bremen, Germany) nuclear magnetic resonance (NMR) spectrometry.…”
Influenza viruses are one of the major causative agents for human respiratory infections. Currently, vaccines and antivirals approved for preventing and treating viral infections are available. However, limited protection efficacy and frequent emergence of drug-resistant viruses stand for a need for the development of antivirals with different chemical skeletons from existing drugs. Screening of a chemical library identified an isoquinolone compound (1) as a hit with 50% effective concentrations (EC50s) between 0.2 and 0.6 µM against the influenza A and B viruses. However, it exhibited severe cytotoxic effects with a 50% cytotoxic concentration (CC50) of 39.0 µM in canine kidney epithelial cells. To address this cytotoxic issue, we synthesized an additional 22 chemical derivatives. Through structure-activity, as well as structure-cytotoxicity relationship studies, we discovered compound 21 that has higher EC50 values ranging from 9.9 to 18.5 µM, but greatly alleviated cytotoxicity with a CC50 value over 300 µM. Mode-of-action and cell type-dependent antiviral experiments indicated that it targets viral polymerase activity and functions also in human cells. Here, we present a new class of viral polymerase inhibitors with a core skeleton of isoquinolone, of which antiviral activity could be better improved through following design and synthesis of its derivatives for drug development.
“…Among 23 isoquinolone compounds, 1 and 17–19 have been synthesized according to our established protocol ( Supplementary Scheme S1 ) [ 11 , 12 ]. Compounds 2 , 3 , 13–15 and 22 without the methylenedioxy group at R 2 were separately synthesized ( Supplementary Scheme S2 ) [ 13 , 14 , 15 , 16 ]. A newly designed synthetic method was used for phensylisoquinolone derivatives 7–10 and 21 , and these compounds were prepared in a one-step cyclization reaction using n-BuLi to link the N,N-diethyl-2-methylbenzamide and benzonitrile moieties ( Scheme 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…Isoquinolone derivatives were synthesized as described previously [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 ]. The structure of newly synthesized compounds 7– 10 and 21 was confirmed by 300 MHz (Varian Unity Plus 300 MHz; Varian Inc., Palo Alto, CA, USA) and 400 MHz (Bruker Ascend 400 MHz; Bruker Daltonik, Bremen, Germany) nuclear magnetic resonance (NMR) spectrometry.…”
Influenza viruses are one of the major causative agents for human respiratory infections. Currently, vaccines and antivirals approved for preventing and treating viral infections are available. However, limited protection efficacy and frequent emergence of drug-resistant viruses stand for a need for the development of antivirals with different chemical skeletons from existing drugs. Screening of a chemical library identified an isoquinolone compound (1) as a hit with 50% effective concentrations (EC50s) between 0.2 and 0.6 µM against the influenza A and B viruses. However, it exhibited severe cytotoxic effects with a 50% cytotoxic concentration (CC50) of 39.0 µM in canine kidney epithelial cells. To address this cytotoxic issue, we synthesized an additional 22 chemical derivatives. Through structure-activity, as well as structure-cytotoxicity relationship studies, we discovered compound 21 that has higher EC50 values ranging from 9.9 to 18.5 µM, but greatly alleviated cytotoxicity with a CC50 value over 300 µM. Mode-of-action and cell type-dependent antiviral experiments indicated that it targets viral polymerase activity and functions also in human cells. Here, we present a new class of viral polymerase inhibitors with a core skeleton of isoquinolone, of which antiviral activity could be better improved through following design and synthesis of its derivatives for drug development.
“…Intramolecular nucleophilic attack of the enamide 107 on the protonated aldehyde then produced the cyclized secondary alcohol 108 , which was oxidized to the final product 38 with pyridinium dichromate. The cyclization of 107 to 108 under acidic conditions, as well as the oxidation of 108 to 38 , had previously been demonstrated by Cho et al during a synthesis in which 107 was set up by reaction of the lithium anion derived from N -methyl- o -methylbenzamide ( 140 ) with PMB-protected o -(hydroxymethyl)benzonitrile ( 141 ) followed by N -methylation, deprotection of the alcohol, and oxidation to the aldehyde 107 (see Scheme below) . The scope of the pathway shown in Scheme was expanded to include products bearing methoxyl groups on the two aromatic rings …”
Section: Impact On the Design And
Execution Of Newer Synthetic Routes...mentioning
confidence: 91%
“…The synthesis outlined in Scheme involves the reaction of the anion derived from deprotonation of the starting material 140 followed by its reaction with the nitrile 141 to yield the intermediate 142 . Alkylation of the anion derived from deprotonation of the amide 142 with methyl iodide afforded the N -methyl derivative 143 , and the protecting group was then removed through oxidation with DDQ and hydrolysis.…”
Section: Impact On the Design And
Execution Of Newer Synthetic Routes...mentioning
The
discovery that certain indenoisoquinolines inhibit the religation
reaction of DNA in the topoisomerase I-DNA-indenoisoquinoline ternary
complex led to a structure-based drug design research program
which resulted in three representatives that entered Phase I clinical
trials in cancer patients at the National Cancer Institute. This has
stimulated a great deal of interest in the design and execution of
new synthetic pathways for indenoisoquinoline production. More recently,
modulation of the substitution pattern and chemical nature of substituents
on the indenoisoquinoline scaffold has resulted in a widening scope
of additional biological targets, including RXR, PARP-1, MYC promoter
G-quadruplex, topoisomerase II, estrogen receptor, VEGFR-2, HIF-1α,
and tyrosyl DNA phosphodiesterases 1 and 2. Furthermore, convincing
evidence has been advanced supporting the potential use of indenoisoquinolines
for the treatment of diseases other than cancer. The rapidly expanding
indenoisoquinoline knowledge base has provided a firm foundation for
further advancements in indenoisoquinoline chemistry, pharmacology,
and therapeutics.
“…treatment of enamide-carbaldehyde 21 with HCl in acetone resulted in the formation of the five-membered C ring of tetracyclic derivatives 22 (Scheme 7). [19][20][21] The transient presence of "TFA dimer" 6a in the course of the BF 3 •H 2 O-catalyzed transformation of 5 was mentioned above, indicating that the primarily formed 6a might be transformed into products 14 and 15. Indeed, treatment of compound 6a with BF 3 •OEt 2 (0.19 eq.)…”
Previously, we have studied the trifluoroacetic acid (TFA)-catalyzed rearrangements of unsubstituted and alkoxy-substituted ortho-(pivaloylaminomethyl)benzaldehydes and revealed the formation of rearranged, regioisomeric aldehydes along with dimer-like products ("TFA dimers"). In the...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.